Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy
- 27 March 2000
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (7) , 729-736
- https://doi.org/10.1038/sj.bmt.1702207
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Variable numbers of BCR‐ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon‐αBritish Journal of Haematology, 1995
- Correlation between the proportion of Philadelphia chromosome‐positive metaphase cells and levels of BCR‐ABL mRNA in chronic myeloid leukaemiaGenes, Chromosomes and Cancer, 1995
- Sequence and Analysis of the Human ABL Gene, the BCR Gene, and Regions Involved in the Philadelphia Chromosomal TranslocationGenomics, 1995
- Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid LeukemiaNew England Journal of Medicine, 1994
- Repeated PCR in CML during IFN‐α therapyEuropean Journal of Haematology, 1994
- Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous LeukemiaAnnals of Internal Medicine, 1991
- Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primersBritish Journal of Haematology, 1990
- ELIMINATION BY INTERFERON-ALPHA OF MALIGNANT CLONE IN CHRONIC MYELOID LEUKAEMIAThe Lancet, 1989
- The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript.Molecular and Cellular Biology, 1986
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973